Tumor-infiltrating lymphocytes, breast cancer subtypes and therapeutic efficacy

被引：88

作者：

Loi, Sherene ^{[1
,2
]}

机构：

[1] Peter MacCallum Canc Ctr, Translat Breast Canc Genom Lab, Canc Therapeut Program, East Melbourne, Vic, Australia

[2] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia

来源：

ONCOIMMUNOLOGY | 2013年 / 2卷 / 07期

关键词：

breast cancer; immunotherapies; biomarkers; tumor infiltrating lymphocytes; prognosis; trastuzumab efficacy; MICROENVIRONMENT; ADJUVANT;

D O I：

10.4161/onci.24720

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

By analyzing over 2000 samples from a randomized clinical trial, we have recently associated high levels of tumor-infiltrating lymphocytes with an excellent prognosis among triple negative breast cancer patients as well with improved clinical responses to immunogenic chemotherapy among patients bearing HER2 over-expression. These findings suggest that immunomodulation could represent a new approach to treat these aggressive breast cancer subtypes.

引用

页数：3

共 50 条

[21] Tumor-infiltrating lymphocytes/macrophages and clinical outcome in breast cancer
Kim, Y-S.
Kim, J-S.
[J]. ANNALS OF ONCOLOGY, 2016, 27
[22] Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in Breast Cancer
Kwa M.
Adams S.
[J]. Current Breast Cancer Reports, 2016, 8 (1) : 1 - 13
[23] In situ cytokine production by breast cancer tumor-infiltrating lymphocytes
Camp, BJ
Dyhrman, ST
Memoli, VA
Mott, LA
Barth, RJ
[J]. ANNALS OF SURGICAL ONCOLOGY, 1996, 3 (02) : 176 - 184
[24] Significance of tumor-infiltrating lymphocytes in breast cancer with neoadjuvant chemotherapy
Miyoshi, Y.
Shien, T.
Omori, M.
Abe, Y.
Watanabe, A.
Hara, A.
Mizoo, T.
Nogami, T.
Taira, N.
Doihara, H.
[J]. BREAST, 2015, 24 : S124 - S124
[25] Nomogram to Predict Tumor-Infiltrating Lymphocytes in Breast Cancer Patients
Feng, Jikun
Li, Jianxia
Huang, Xinjian
Yi, Jiarong
Wu, Haoming
Zou, Xuxiazi
Zhong, Wenjing
Wang, Xi
[J]. FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
[26] Spatial Characterization of Tumor-Infiltrating Lymphocytes and Breast Cancer Progression
Fassler, Danielle J.
Torre-Healy, Luke A.
Gupta, Rajarsi
Hamilton, Alina M.
Kobayashi, Soma
Van Alsten, Sarah C.
Zhang, Yuwei
Kurc, Tahsin
Moffitt, Richard A.
Troester, Melissa A.
Hoadley, Katherine A.
Saltz, Joel
[J]. CANCERS, 2022, 14 (09)
[27] Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer
Leon-Ferre, Roberto A.
Jonas, Sarah Flora
Salgado, Roberto
Loi, Sherene
de Jong, Vincent
Carter, Jodi M.
Nielsen, Torsten O.
Leung, Samuel
Riaz, Nazia
Chia, Stephen
Jules-Clement, Gerome
Curigliano, Giuseppe
Criscitiello, Carmen
Cockenpot, Vincent
Lambertini, Matteo
Suman, Vera J.
Linderholm, Barbro
Martens, John W. M.
van Deurzen, Carolien H. M.
Timmermans, A. Mieke
Shimoi, Tatsunori
Yazaki, Shu
Yoshida, Masayuki
Kim, Sung-Bae
Lee, Hee Jin
Dieci, Maria Vittoria
Bataillon, Guillaume
Vincent-Salomon, Anne
Andre, Fabrice
Kok, Marleen
Linn, Sabine C.
Goetz, Matthew P.
Michiels, Stefan
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 331 (13): : 1135 - 1144
[28] Novel tumor-infiltrating lymphocytes ultrasonography score based on ultrasonic tissue findings predicts tumor-infiltrating lymphocytes in breast cancer
Fukui, Kayo
Masumoto, Norio
Shiroma, Noriyuki
Kanou, Akiko
Sasada, Shinsuke
Emi, Akiko
Kadoya, Takayuki
Yokozaki, Michiya
Arihiro, Koji
Okada, Morihito
[J]. BREAST CANCER, 2019, 26 (05) : 573 - 580
[29] Role of tumor-infiltrating gammadelta T lymphocytes in breast cancer
Ma, Chunling
Zhang, Qunyuan
Ye, Jian
Zhang, Yanping
Wevers, Eric
Schwartz, Theresa
Hunborg, Pamela
Vavares, Mark A.
Hoft, Daniel F.
Hsueh, Eddy C.
Peng, Guangyong
[J]. CANCER RESEARCH, 2012, 72
[30] Tumor-infiltrating lymphocytes are associated with β-catenin overexpression in breast cancer
Ma, Xingcong
Zhao, Xiaoyao
Yan, Wanjun
Yang, Jun
Zhao, Xixi
Zhang, Hong
Hui, Yuxin
Zhang, Shuqun
[J]. CANCER BIOMARKERS, 2018, 21 (03) : 639 - 650

← 1 2 3 4 5 →